| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating costs and expenses | ||||||||
Research and development | ||||||||
2,537 | 2,025 | 1,241 | 1,051 | 878 | 785 | 0 | 0 | 0 |
Research and development - licenses acquired (including stock-based compensation) | ||||||||
124 | 95 | 70 | 86 | 108 | 230 | 0 | 0 | 0 |
Compensation and related expenses (including stock-based compensation) | ||||||||
2,777 | 2,932 | 885 | 645 | 722 | 509 | 0 | 0 | 0 |
Professional fees (including stock-based compensation) | ||||||||
2,604 | 2,091 | 1,634 | 1,099 | 784 | 682 | 0 | 0 | 0 |
Rent | ||||||||
33 | 31 | 31 | 31 | 29 | 28 | 0 | 0 | 0 |
Other expenses | ||||||||
625 | 538 | 518 | 388 | 274 | 258 | 0 | 0 | 0 |
Total operating expenses | ||||||||
8,702 | 7,714 | 4,381 | 3,301 | 2,797 | 2,495 | 0 | 0 | 0 |
Loss from operations | ||||||||
-8,702 | -7,714 | -4,381 | -3,301 | -2,797 | -2,495 | 0 | 0 | 0 |
Other expenses | ||||||||
Other expense, net | ||||||||
0 | - | 0 | - | - | - | - | - | - |
Total other expenses | ||||||||
0 | - | 0 | - | - | - | - | - | - |
Net loss | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Net loss | ||||||||
- | - | -4,377 | -3,301 | - | -2,495 | 0 | 0 | 0 |
Weighted average number of common shares outstanding, basic and diluted | ||||||||
10,251 | 10,161 | 9,886 | 9,603 | 7,007 | 5,072 | 5,079 | 5,039 | 4,932 |
Net loss per share, basic and diluted | ||||||||
-0.18 | -0.42 | -0.17 | -0.13 | -0.12 | -0.12 | -0.12 | -0.15 | -0.11 |